This study examines the feasibility and acceptability of a web-based intervention program for women with anxiety after childbirth, potential anxiety reduction after the intervention and determines the feasibility of the study design (randomized controlled design) and recruitment for the intervention in this population to inform the protocol (including effect size and study power) for a randomized controlled trial.
Background: What Am I Worried About (WAWA) is a self-help booklet intervention for women experiencing anxiety after birth based on cognitive-behavioural and mindfulness principles developed in Australia. The WAWA booklet was found to be acceptable, safe, stigma free, feasible, and demonstrated preliminary efficacy in Australia. A web-based version of WAWA for the use in the United-Kingdom (UK) was developed at City University London in collaboration with the intervention development team in Australia. However, before dissemination the web-based version of WAWA (iWAWA) in the UK it is deemed important to evaluate the program. Therefore, this study aims to examine the feasibility, acceptability, and potential efficacy of this web-based intervention program for women with anxiety after childbirth in the UK. The primary objectives of the proposed study are to: conduct a randomized controlled trial and * examine the feasibility of web-based treatment program (iWAWA) in terms of engagement and usability. * examine user's acceptability of iWAWA in terms of usefulness, satisfaction, and credibility. The secondary objectives of this study are to: * obtain initial estimates of anxiety levels and examine potential patient improvement over the course of the intervention and compared to the control group. * determine the feasibility of the study by examining recruitment, consent, attrition, follow-up rates, as well as response rates to questionnaires. Method: For this feasibility study, an embedded mixed methods design is employed utilizing both quantitative and qualitative methods to achieve the above stated aims. For the quantitative part, a randomized control trial is conducted. Outcomes are assessed at pre-intervention, throughout the intervention, post-intervention, and 1-month post-intervention. For the qualitative part, semi-structured interviews are used for a more in-depth exploration of acceptability and feasibility of the iWAWA intervention. The interviews with participants are carried out post intervention. Study benefits: Based on the participants' feedback, this study hopes to inform development and adaptation of the investigated web-based intervention. If the interventions acceptability and feasibility is confirmed, the next steps would be to test the intervention efficacy in a stage II randomized control trial.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
89
This web-based intervention consists of three sections: 1) Is this for me? 2) Practice 3) Understanding. The three main sections are divided up into nine sessions. Participants will get access to the program for eight weeks and can access the sessions more than once. Sessions are made up of multimedia presentations and worksheets that are completed online.
City, University of London
London, Greater London, United Kingdom
City University of London
London, United Kingdom
Engagement as measured by the number of log-ins into the web-based intervention
Time frame: At time of intervention (8 weeks)
Engagement as measured by the duration of log-ins into the web-based intervention
Time frame: At time of intervention (8 weeks)
Engagement as measured by the total duration of time spent on the web-based intervention
Time frame: At time of intervention (8 weeks)
Engagement as measured by the time spent on individual pages of the web-based intervention
Time frame: At time of intervention (8 weeks)
Engagement as measured by the number of intervention coach calls
Time frame: At time of intervention (8 weeks)
Usability as measured by participant's report of usefulness ("I found this module useful.") of each intervention module on a 7-point Likert scale (1 = strongly disagree to 7 = strongly agree).
Time frame: At time of intervention (8 weeks) after each completed intervention module
Usability as measured by participant's report of clarity ("This module was clear and understandable.") of each intervention module on a 7-point Likert scale (1 = strongly disagree to 7 = strongly agree).
Time frame: At time of intervention (8 weeks) after each completed intervention module
Usability as measured by participant's report of usability on the System Usability Scale (SUS)
The System Usability Scale (SUS) is a 10-item instrument rated on 5-point Likert scale (1 = strongly disagree to 5 = strongly agree) and participants are asked to rate the degree to which they agree with positive and negative descriptions of a program. The SUS will be adapted for this study by replacing 'the system/product' with 'iWAWA' for all items. Higher scores indicate better usability.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Within 2 weeks after the intervention
Usability as measured by participant's report of usability on a series of items designed to measure ease-of-use and unobtrusiveness on 7-point Likert scale (1 = strongly disagree to 7 = strongly agree)
Time frame: Within 2 weeks after the intervention
Usability as measured by participant's report of any technical problems experienced with the intervention website
Time frame: Within 2 weeks after the intervention
Usability as measured by participant's report of interest in future usage of the intervention
Time frame: Within 2 weeks after the intervention
Usefulness as measured by participant's report of a series of items designed to measure perceived usefulness on a 7-point Likert scale (1 = strongly disagree to 7 = strongly agree).
Time frame: Within 2 weeks after the intervention
Satisfaction as measured by participant's report of a series of items designed to measure perceived satisfaction on a 7-point Likert scale (1 = strongly disagree to 7 = strongly agree).
Time frame: Within 2 weeks after the intervention
Satisfaction as measured by participant's report on the Client Satisfaction Questionnaire (CSQ-8)
The Client Satisfaction Questionnaire (CSQ-8) will further be used and adapted to assess satisfaction. The CSQ-8 consists of eight items which are rated on 5-point Likert scale. The CSQ-8 will be adapted for this study by substituting 'service' with 'help" and "program" with "iWAWA" in all items.
Time frame: Within 2 weeks after the intervention
Credibility as measured by participant's report on the first 4 items of Credibility/ Expectancy Questionnaire (CEQ)
The Credibility/ Expectancy Questionnaire (CEQ) is a 6-item widely applied measure of the expectancies or perception of intervention credibility and will be adapted for the use in this study.
Time frame: Within 2 weeks after the intervention
Women's perspectives and experiences as measured by semi-structured interviews
Time frame: Within 8 weeks after the intervention
Engagement as measured by the duration of intervention coach calls
Time frame: Continuous throughout the 8 week intervention period
Usability as measured by participant's report of hypothetical recommendation of the intervention to others.
Time frame: Within 2 weeks after the intervention
Anxiety level as measured by participant's report on the Generalized Anxiety Disorder Scale (GAD-7)
The Generalized Anxiety Disorder Scale (GAD-7) is a seven-item anxiety measure and items are rated on 4-point Likert-scale ranging from 0' (not at all) to '3' (nearly every day).
Time frame: Within 1 week before the intervention
Depression, anxiety and stress symptomatology as measured by participant's report on the Depression, Anxiety, and Stress Scale (DASS 21)
The Depression, Anxiety, and Stress Scale (DASS 21) is a 21-item self-report measure of current depressive, anxiety, and stress symptoms. Low positive affect, reduced self-esteem and motivation, and a sense of hopelessness is assessed by seven depression items; fearfulness and physiological arousal is assessed by seven anxiety items, and tension, irritability and a low threshold to frustration are measured by seven stress items. Higher scores indicate more severe symptoms.
Time frame: Within 1 week before the intervention
Anxiety level as measured by participant's report on the Generalized Anxiety Disorder Scale (GAD-7)
The Generalized Anxiety Disorder Scale (GAD-7) is a seven-item anxiety measure and items are rated on 4-point Likert-scale ranging from 0' (not at all) to '3' (nearly every day).
Time frame: Within 1 week after the intervention
Depression, anxiety and stress symptomatology as measured by participant's report on the Depression, Anxiety, and Stress Scale (DASS 21)
The Depression, Anxiety, and Stress Scale (DASS 21) is a 21-item self-report measure of current depressive, anxiety, and stress symptoms. Low positive affect, reduced self-esteem and motivation, and a sense of hopelessness is assessed by seven depression items; fearfulness and physiological arousal is assessed by seven anxiety items, and tension, irritability and a low threshold to frustration are measured by seven stress items. Higher scores indicate more severe symptoms.
Time frame: Within 1 week after the intervention
Anxiety level as measured by participant's report on the Generalized Anxiety Disorder Scale (GAD-7)
The Generalized Anxiety Disorder Scale (GAD-7) is a seven-item anxiety measure and items are rated on 4-point Likert-scale ranging from 0' (not at all) to '3' (nearly every day).
Time frame: Within 1 week after the end of the 4 week post-intervention follow-up period
Depression, anxiety and stress symptomatology as measured by participant's report on the Depression, Anxiety, and Stress Scale (DASS 21)
The Depression, Anxiety, and Stress Scale (DASS 21) is a 21-item self-report measure of current depressive, anxiety, and stress symptoms. Low positive affect, reduced self-esteem and motivation, and a sense of hopelessness is assessed by seven depression items; fearfulness and physiological arousal is assessed by seven anxiety items, and tension, irritability and a low threshold to frustration are measured by seven stress items. Higher scores indicate more severe symptoms.
Time frame: Within 1 week after the end of the 4 week post-intervention follow-up period
Study feasibility as measured by recruitment rate
Time frame: Within 4 weeks of ending recruitment
Study feasibility as measured by eligibility rate
Time frame: Within 4 weeks of ending recruitment
Study feasibility as measured by consent rate
Time frame: Within 4 weeks of ending recruitment
Study feasibility as measured by retention rate
Time frame: Within 4 weeks of ending data collection
Study feasibility as measured by pre-intervention data collection rate
Time frame: Within 4 weeks of ending data collection
Study feasibility as measured by pre-intervention data collection completeness
Time frame: Within 4 weeks of ending data collection
Study feasibility as measured by post-intervention data collection rate
Time frame: Within 4 weeks of ending data collection
Study feasibility as measured by post-intervention data collection completeness
Time frame: Within 4 weeks of ending data collection
Study feasibility as measured by 4 week post intervention follow-up data collection rate
Time frame: Within 4 weeks of ending data collection
Study feasibility as measured by 4 week post intervention follow-up data collection completeness
Time frame: Within 4 weeks of ending data collection